[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100518839":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":33,"centralContacts":37,"locations":43,"responsibleParty":60,"collaborators":41,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":41,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":41,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":41,"overallStatus":45,"whyStopped":41,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Konkuk University Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"group pyridostigmine","ACTIVE_COMPARATOR","If TOF count is 1 or less, wait until it becomes 2 and then give the patient pyridostigmine dose of 350mcg\u002Fkg. If TOF count shows 4 with fade, 350mcg\u002Fkg of pyridostigmine is administered and without fade, 200mcg\u002Fkg is administered.",[13],"Drug: Pyridostigmine Bromide 5 MG\u002FML",{"label":15,"type":10,"description":16,"interventionNames":17},"group sugammadex","If TOF count shows 0 and PTC (posttetanic count) is 1 or more, sugammadex administered dose of 4mg\u002Fkg. If TOF count shows 1 or more, 2mg\u002Fkg is administered.",[18],"Drug: Bridion 200 MG in 2 ML Injection",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Bridion 200 MG in 2 ML Injection","Sugammadex is administered at the end of surgery after assessment of the level of neuromuscular blockade is done. The dosage of each reversal agent is determined with response to TOF or PTC.",[15],[26],"Sugammadex",{"type":21,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Pyridostigmine Bromide 5 MG\u002FML","Pyridostigmine is administered at the end of surgery after assessment of the level of neuromuscular blockade is done. The dosage of each reversal agent is determined with response to TOF.",[9],[32],"Pyridostigmine",[34],{"name":35,"affiliation":5,"role":36},"Yea-Ji Lee, M.D Ph. D","PRINCIPAL_INVESTIGATOR",[38],{"name":35,"role":39,"phone":40,"phoneExt":41,"email":42},"CONTACT","+82-2-2030-5450",null,"ladydaisy82@naver.com",[44],{"facility":5,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":41,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Seoul","Seoul-T'ǔkpyǒlshi","05030","South Korea",{"type":51,"coordinates":52},"Point",[53,54],126.9784,37.566,{"lat":54,"lon":53},[57],{"name":58,"role":39,"phone":59,"phoneExt":41,"email":42},"Yea-Ji Lee","01086307701",{"type":36,"investigatorFullName":58,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":41,"oldOrganization":41},"Assisstant professor","100518839","phase-4-the-occurrence-of-emergence-agitation-in-pediatric-strabismus-surgery-100518839",false,"NCT06035757","The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery","The Effect of Administration of Sugammadex on the Occurrence of Emergence Agitation in Pediatric Strabismus Surgery-prospective Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients scheduled elective strabismus surgery aged 4-7 with American Society of Anesthesiologists (ASA) classification 1-3.\n\nExclusion Criteria:\n\n* ASA classification 3 or more\n* impaired liver function\n* impaired kidney function\n* myasthenia gravis or other neuromuscular disorders\n* history of drug allergy\n* cardiovascular disease or arrhythmia",true,"ALL","4 Years","7 Years",{"count":74,"type":75},76,"ESTIMATED","INTERVENTIONAL",[78],"PHASE4","The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine",[81,82,83],"Emergence Delirium","Strabismus","Pediatric ALL","2026-03-01",{"date":86,"type":87},"2026-03-03","ACTUAL",{"date":89,"type":87},"2023-12-01",{"date":91,"type":75},"2026-03-30",{"name":5,"class":6},1]